Fiduciary/Claymore MLP Opportunity Fund Announces Pricing

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Fiduciary/Claymore MLP Opportunity Fund Announces Pricing of Public Offering of Common Shares

LISLE, Ill., Sept. 10, 2013 (GLOBE NEWSWIRE) -- Fiduciary/Claymore MLP Opportunity Fund (the "Fund") (NYSE: FMO ) today announced the pricing of a public offering of common shares. The Fund agreed to sell a total of 2,850,000 common shares (exclusive of 427,500 common shares that the underwriters may purchase pursuant to a 45-day option to cover over-allotments) at a price of $25.21 per share. Net proceeds from the offering of approximately $68.6 million will be used to make additional portfolio investments that are consistent with the Fund's investment objective and for general corporate purposes. The offering is scheduled to close on September 13, 2013.

Morgan Stanley & Co. LLC, Citigroup Global Markets Inc., UBS Securities LLC and RBC Capital Markets, LLC acted as joint book running managers for the offering; Robert W. Baird & Co. Incorporated and Maxim Group LLC acted as co-managers for the offering. The offering of these securities will be made only by means of a prospectus. A copy of the preliminary prospectus supplement and accompanying base prospectus relating to the offering may be obtained from the following addresses:

Morgan Stanley & Co. LLC
Attn: Prospectus Department
180 Varick Street, 2 nd Floor
New York, NY 10014
Telephone: 866-718-1649

Citigroup
c/o: Broadridge Financial Solutions
1155 Long Island Avenue
Edgewood, NY 11717
Telephone: 800-831-9146
Email: batprospectusdept@citi.com

UBS Securities LLC
Attn: Prospectus Department
299 Park Avenue
New York, NY 10171
Telephone: 888-827-7275

RBC Capital Markets, LLC
Attn: Equity Syndicate
Three World Financial Center
200 Vesey Street, 8 th Floor
New York, NY 10281
Telephone: 212-428-6670

Robert W. Baird & Co. Incorporated
Attn: Syndicate Department
777 E. Wisconsin Avenue
Milwaukee, WI 53202
Telephone: 800-792-2413

Maxim Group LLC
Attn: Prospectus Department
405 Lexington Avenue
New York, NY 10022
Telephone: 800-724-0761

Investors may also obtain these documents free of charge from the Securities and Exchange Commission's website at www.sec.gov .

An investor should read the Fund's preliminary prospectus supplement and accompanying base prospectus carefully before investing. The preliminary prospectus supplement and accompanying base prospectus contain important information about the Fund and its investment objective and policies, risks, charges and expenses.

This press release does not constitute an offer to sell or a solicitation to buy the securities described herein, nor shall there be any sale of these securities in any state or jurisdiction in which such offer or solicitation or sale would be unlawful prior to registration or qualification under the laws of such state or jurisdiction.

A registration statement relating to these securities was filed with, and has been declared effective by, the Securities and Exchange Commission. The securities being offered have not been approved or disapproved by any regulatory authority, nor has any such authority passed upon the accuracy or adequacy of the prospectus supplement, prospectus or shelf registration statement.

The Fund is a non-diversified, closed-end management investment company. The Fund's investment objective is to provide a high level of after-tax total return with an emphasis on current distributions paid to shareholders. No assurance can be given that the Fund's investment objective will be achieved.

Guggenheim Investments represents the investment management division of Guggenheim Partners, LLC ("Guggenheim"), which consists of investment managers with approximately $151 billion in combined total assets*. Collectively, Guggenheim Investments has a long, distinguished history of serving institutional investors, ultra-high-net-worth individuals, family offices and financial intermediaries. Guggenheim Investments offers clients a wide range of differentiated capabilities built on a proven commitment to investment excellence. Guggenheim Investments has offices in Chicago, New York City and Santa Monica, along with a global network of offices throughout the United States, Europe, and Asia.

Guggenheim Investments is comprised of several investment management entities within Guggenheim, which includes Guggenheim Funds Investment Advisors, LLC. Guggenheim Funds Investment Advisors, LLC serves as Investment Adviser for FMO . For more information regarding the Funds, please visit www.guggenheiminvestments.com/fmo .

*The total asset figure is as of 6.30.2013 and includes $11.720B of leverage and $0.331B of leverage for Serviced Assets. AUM includes assets from Security Investors, Guggenheim Partners Investment Management, LLC, Guggenheim Funds Investment Advisors and its affiliated entities, and some business units including Guggenheim Real Estate, Guggenheim Aviation, GS GAMMA Advisors, Guggenheim Partners Europe, Transparent Value Advisors, and Guggenheim Partners India Management. Values from some funds are based upon prior periods.

Advisory Research, Inc. serves as the Fund's investment sub-adviser. The FAMCO MLP team, a division of the Sub-Adviser, is responsible for the management of the Fund's portfolio of securities. The FAMCO MLP team is dedicated to managing MLPs and energy infrastructure strategies for open and closed-end mutual funds, public and corporate pension plans, endowments and foundations and private wealth individuals. In March 2012, the FAMCO MLP team and its business was transferred from Fiduciary Asset Management Inc. (the "Predecessor Sub-Adviser") to the Sub-Adviser. Each of the Sub- Adviser and the Predecessor Sub-Adviser is a wholly owned subsidiary of Piper Jaffray Companies.

Because of the Fund's concentration in MLP investments, the Fund is not eligible to be treated as a "regulated investment company" under the Internal Revenue Code of 1986, as amended (the "Code"). Instead, the Fund is treated as a regular corporation for U.S. federal income tax purposes and, as a result, unlike most investment companies, is subject to corporate income tax to the extent the Fund recognizes taxable income. The Fund anticipates that a significant portion of the distributions received by the Fund from the MLPs in which it invests will consist of return of capital. If this expectation is not realized, the Fund will have a larger corporate income tax expense sooner than expected, which will result in less cash available to distribute to common shareholders in such taxable years. Moreover, although MLP distributions that are treated as returns of capital are generally not taxable to the Fund to that extent, such returns of capital reduce the Fund's tax basis in its investments, resulting in potential increased gains (or decreased losses) upon dispositions of such investments. While the Fund will generally seek to maximize the portion of the Fund's distributions to common shareholders that will consist of return of capital, no assurance can be given in this regard.

This information does not represent an offer to sell securities of the Fund and it is not soliciting an offer to buy securities of the Fund. There can be no assurance that the Fund will achieve its investment objective. Investments in the Fund involve operating expenses and fees. The net asset value of the Fund will fluctuate with the value of the underlying securities. It is important to note that closed-end funds trade on their market value, not net asset value, and closed-end funds often trade at a discount to their net asset value. Past performance is not indicative of future performance. An investment in the Fund is subject to investment risk, including the possible loss of the entire amount that you invest. Some general risks and considerations associated with investing in the Fund include: Risks of Investing in MLP Units, Tax Risks of Investing in Equity Securities of MLPs, Affiliated Party Risk, Equity Securities Risk, Concentration Risk, Energy Sector Risks, Other Sector Risks, Small Capitalization Risk, Restricted Securities Risk, Cash Flow Risk, Risk Associated with Options on Securities, Liquidity Risk, Valuation Risk, Interest Rate Risk, Lower Grade Securities Risk, Portfolio Turnover Risk, Foreign Securities Risk, Derivatives Risk, Market Discount Risk, Other Investment Companies Risk, Royalty Trust Risk, Leverage Risk, Non-diversified Status Risk, Management Risk and Current Developments Risk.

Investors should consider the investment objective and policies, risk considerations, charges and expenses of any investment before they invest. For this and more information visit www.guggenheiminvestments.com or contact a securities representative or Guggenheim Funds Distributors, LLC 2455 Corporate West Drive, Lisle, IL 60532, 800-345-7999.

NOT FDIC-INSURED | NOT BANK-GUARANTEED | MAY LOSE VALUE

Member FINRA/SIPC (9/13)

Analyst Inquiries William T. Korver 630.505.3700 Media Inquiries Jeaneen Pisarra 212.518.5367

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Zenni and Chase Stokes Foster Student Wellbeing in NYC

Updated Category News Views 3

Picture this: near 300 high schoolers milling around, glancing through shiny new glasses from the Zenni x Chase Stokes collection. In the heart of New York City, these kids are getting a double-dose of care that's all too rare—free vision screenings paired with mental health support. It's the kind of collaboration that shows you what's possible when a company, an actor,...

Continue Reading
Duke Energy Braces for Isaias: Key Prep Steps Ahead

Updated Category News Views 6

Brace Yourself: Duke Energy Gears Up for Isaias In the ever-unpredictable game of Mother Nature versus infrastructure, Duke Energy is stepping into the ring once more, readying to tackle potential outages across the Carolinas as Hurricane Isaias edges near. Listen, if there's one thing I've learned over years of watching these weather events unfold on the stock ticker and...

Continue Reading
Helio Genomics Shakes Up Liver Cancer Detection Strategy

Updated Category News Views 5

Rethinking Liver Cancer Detection with HelioLiver Sometimes you stumble upon a tech piece that might genuinely shake up the game. Helio Genomics just poured some serious intel at the San Antonio Liver Cancer Symposium, showcasing how their HelioLiver Dx might outgun traditional scans in sniffing out hepatocellular carcinoma (HCC). They threw down four studies revealing...

Continue Reading
Icebox Takes on Buckhead with Diamonds and Discounts

Updated Category News Views 4

So, Atlanta's Icebox Diamonds & Watches just dropped a news bomb that could shake up anyone with a taste for glitz and a wallet ready to act. This iconic jeweler, swinging its roots from a humble family biz to a global gem, is opening up its vault with an Inventory Reduction Sale starting October 9. And folks, it’s happening right at their Buckhead flagship showroom....

Continue Reading
Toyland 2026: Blain's 'Open The Magic' Event Marks 69 Years

Updated Category News Views 5

There's something about nostalgia that hooks you right in the gut, like remembering those jittery walks through Blain's Farm & Fleet's Toyland aisles. If there's one thing these folks know, it's how to spark holiday cheer deep in the Midwest bones. Here we are, just before the dust settles on another year, and Blain's is rolling out its 69th Toyland party—a cherished...

Continue Reading
CellFiber Expands to Philly: Boosting US Biotech Scene

Updated Category News Views 5

CellFiber's Leap into 'Cellicon Valley' Folks, when the biotech winds start blowing, you better have your sails up. CellFiber Co., Ltd., a Tokyo-based innovator, has landed itself a comfy spot in the City of Brotherly Love. We're talking Philadelphia, folks, or, as it's dubbed in certain circles, 'Cellicon Valley.' Now if that's not a name that screams biotech pedigree, I...

Continue Reading
Korea Tourism’s Quiz Offers Free Trip Sweepstakes

Updated Category News Views 4

A Shot at Adventure Without Opening Your Wallet Let me tell you, Korea's got a way of sweeping folks off their feet with a little something for everyone—from a foodie’s paradise to history buff heaven. The Korea Tourism Organization's (KTO) New York Office is lighting up the stage with a slick offer: enter a quiz on their website and you might just be jetting off to...

Continue Reading
NCICU's Digital Boost for NC Transfer Students

Updated Category News Views 4

New Platform Eases the Transfer Struggle They’ve finally cooked up something good for the college crowd in North Carolina. The NCICU, with the NCCCS, has rolled out a platform called Transfer Pathways to simplify students' path from two-year to four-year schools. This ain't just a tweak—it's backed by a hefty $2 million in grants. Hats off to those...

Continue Reading
Mastering Packaging Costs: Beyond the Box Price

Updated Category News Views 5

Peeling Back the Layers of Packaging Costs Packaging's a bit like an onion—every layer you peel back reveals another cost you didn’t see at first glance. Folks in the know, like Kyle Reger of Jamestown Container Companies, are flipping the script on how we approach packaging expenses. It's not just about snagging the cheapest box on the shelf anymore. There's a whole...

Continue Reading
India's Women Apparel Market Grows Amid Innovation

Updated Category News Views 4

India's Women Apparel Market on the Rise The winds of fashion change are sweeping through India, and the women's apparel market is at the heart of this sartorial hurricane. Set to explode from USD 28,786.82 million in 2024 to USD 45,491.96 million by 2032, this market is turning heads with a compound annual growth rate (CAGR) of 5.21%. What's stirring this pot, you ask?...

Continue Reading

Top 5 Most Recently Viewed Articles

Growth Trends in Indolent Lymphoma Therapy Market Explained

Updated Category News Views 163

Understanding the Indolent Lymphoma Market Growth The indolent lymphoma market is currently experiencing significant growth, driven primarily by the rising incidence of slow-growing non-Hodgkin lymphomas and increased awareness regarding early diagnosis. Notably, the introduction of innovative therapies has played a substantial role in this expansion. Emerging treatments...

Continue Reading
Families Seek Quality Schools: What to Consider This Season

Updated Category News Views 112

Families Choosing Top-School Districts for Relocation As families prepare to relocate, many are prioritizing school districts known for their exceptional educational offerings. This trend is evident as households focus on neighborhoods with reputable schools, enhancing both their living standards and their children's learning opportunities. The latest analysis has...

Continue Reading
Empowering Women: Highlights from the Abuser's Playbook Workshop

Updated Category News Views 119

Empowering Women Through Knowledge and Advocacy Recently, authors Amy Polacko and Dr. Christine M. Cocchiola, known for their powerful book, Framed: Women in the Family Court Underworld, organized a significant workshop with the support of Mommy's Heart. Held at a venue in New York City, this workshop addressed the challenges women face in family court settings,...

Continue Reading
Zealand Pharma Wrapping Up ZUPREME-1 Trial Enrollment Success

Updated Category News Views 231

Zealand Pharma Successfully Completes Enrollment in ZUPREME-1 Trial Zealand Pharma A/S (NASDAQ: ZEAL), a biotechnology company dedicated to innovating peptide-based medicines, has proudly announced the completion of participant enrollment in the Phase 2b ZUPREME-1 clinical trial. This exciting milestone comes shortly after the trial's inception, marking significant...

Continue Reading
Protective Clothing Sector Projected to Hit $18.6 Billion by 2033

Updated Category News Views 106

Projected Growth of the Protective Clothing Market The protective clothing market is on an exciting upward trajectory, expected to reach an impressive valuation of $18.6 billion within the next decade. This anticipated growth, at a compound annual growth rate (CAGR) of 6.1% from 2024 to 2033, reflects the increasing awareness towards workplace safety and the growing need...

Continue Reading